Mcalester Regional Health Center | |
One Clark Bass Boulevard, Mcalester, Oklahoma 74501 | |
(918) 426-1800 | |
Name | Mcalester Regional Health Center |
---|---|
Type | Acute Care Hospital |
Location | One Clark Bass Boulevard, Mcalester, Oklahoma |
Ownership | Voluntary non-profit - Other |
Emergency Services | Yes |
Medicare ID (CCN) | 370034 |
NPI Number | 1316940034 |
Organization Name | MCALESTER REGIONAL HEALTH CENTER AUTHORITY |
Doing Business As | MCALESTER REGIONAL HEALTH CENTER |
Address | 1 E Clark Bass Blvd, Mcalester, OK 74501 |
Hospital Type | General Acute Care Hospital - Rural |
Phone Number | 918-426-1800 |
News Archive
SP Scientific has entered into an exclusive agreement with Physical Sciences Inc.
As India reports record high daily covid-19 cases and deaths, a group of leading doctors say India must stop mass gatherings and consider postponing its forthcoming elections.
Immune Pharmaceuticals Inc. announced today that it has initiated its Phase II Ulcerative Colitis clinical trial and is scheduled to initiate its Phase II Bullous Pemphigoid clinical trial on July 1, 2015. Study Initiation is the training of hospital staff to allow for patient screening and immediate patient enrollment into the clinical trial upon selection.
With more than 7.5 million new cases of Alzheimer's disease a year, the race to find a vaccine and effective treatment for dementia is growing by the day.
Aelan Cell Technologies today announced the development of a novel epigenetic biomarker. An early human clinical feasibility study has indicated that serological tests using the biomarker alongside other proprietary components developed by Aelan's researchers could potentially help physicians diagnose Alzheimer's disease (AD).
› Verified 1 days ago
NPI Number | 1568631877 |
Organization Name | MCALESTER REGIONAL HEALTH CENTER AUTHORITY |
Doing Business As | MCALESTER REGIONAL SNF |
Address | 1 E Clark Bass Blvd, Mcalester, OK 74501 |
Hospital Type | General Acute Care Hospital - Rural |
Phone Number | 918-426-1800 |
News Archive
SP Scientific has entered into an exclusive agreement with Physical Sciences Inc.
As India reports record high daily covid-19 cases and deaths, a group of leading doctors say India must stop mass gatherings and consider postponing its forthcoming elections.
Immune Pharmaceuticals Inc. announced today that it has initiated its Phase II Ulcerative Colitis clinical trial and is scheduled to initiate its Phase II Bullous Pemphigoid clinical trial on July 1, 2015. Study Initiation is the training of hospital staff to allow for patient screening and immediate patient enrollment into the clinical trial upon selection.
With more than 7.5 million new cases of Alzheimer's disease a year, the race to find a vaccine and effective treatment for dementia is growing by the day.
Aelan Cell Technologies today announced the development of a novel epigenetic biomarker. An early human clinical feasibility study has indicated that serological tests using the biomarker alongside other proprietary components developed by Aelan's researchers could potentially help physicians diagnose Alzheimer's disease (AD).
› Verified 1 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
SP Scientific has entered into an exclusive agreement with Physical Sciences Inc.
As India reports record high daily covid-19 cases and deaths, a group of leading doctors say India must stop mass gatherings and consider postponing its forthcoming elections.
Immune Pharmaceuticals Inc. announced today that it has initiated its Phase II Ulcerative Colitis clinical trial and is scheduled to initiate its Phase II Bullous Pemphigoid clinical trial on July 1, 2015. Study Initiation is the training of hospital staff to allow for patient screening and immediate patient enrollment into the clinical trial upon selection.
With more than 7.5 million new cases of Alzheimer's disease a year, the race to find a vaccine and effective treatment for dementia is growing by the day.
Aelan Cell Technologies today announced the development of a novel epigenetic biomarker. An early human clinical feasibility study has indicated that serological tests using the biomarker alongside other proprietary components developed by Aelan's researchers could potentially help physicians diagnose Alzheimer's disease (AD).
› Verified 1 days ago
Mcalester Regional Health Center Acute Care Hospital Location: One Clark Bass Boulevard, Mcalester, Oklahoma 74501 Phone: (918) 426-1800 | |
Carl Albert Community Mental Health Center Psychiatric Hospital Location: 1101 East Monroe, Mcalester, Oklahoma 74501 Phone: (918) 426-7800 |